QuiVad

Home / Funds / Guevoura Fund

Guevoura Fund

The short positions this fund discloses today, across every market.

Follow

Open short positions, the heaviest first.
IssuerMarket% of capitalSince
Precise Biometrics ABSweden0.75%August 10, 2026

History of disclosures

310 disclosures on record for this fund.
DateIssuerMarket% of capitalEnd of publication
February 3, 2025Fingerprint Cards ABSweden1.56%still open
January 30, 2025Fingerprint Cards ABSweden1.32%still open
January 28, 2025Fingerprint Cards ABSweden1.21%still open
December 20, 2024Metacon AB (publ)Sweden0.50%still open
December 9, 2024Flat Capital AB (publ)Sweden1.93%still open
December 6, 2024Flat Capital AB (publ)Sweden1.88%still open
December 4, 2024Flat Capital AB (publ)Sweden1.73%still open
December 3, 2024Flat Capital AB (publ)Sweden1.66%still open
December 2, 2024Flat Capital AB (publ)Sweden1.44%still open
November 29, 2024Flat Capital AB (publ)Sweden1.63%still open
November 28, 2024Flat Capital AB (publ)Sweden1.50%still open
November 27, 2024Flat Capital AB (publ)Sweden1.05%still open
September 26, 2024Immunovia AB (publ)Sweden1.30%still open
September 25, 2024Immunovia AB (publ)Sweden1.15%still open
September 18, 2024Ascelia Pharma ABSweden0.80%still open
September 13, 2024Ascelia Pharma ABSweden0.78%still open
September 11, 2024Ascelia Pharma ABSweden0.60%still open
September 10, 2024Ascelia Pharma ABSweden1.36%still open
September 10, 2024Dicot Pharma ABSweden1.25%still open
September 9, 2024Ascelia Pharma ABSweden0.92%still open
September 9, 2024Immunovia AB (publ)Sweden0.80%still open
September 6, 2024Dicot Pharma ABSweden2.61%still open
September 5, 2024Dicot Pharma ABSweden2.55%still open
September 5, 2024Logistea ABSweden0.60%still open
September 4, 2024Dicot Pharma ABSweden2.40%still open
September 4, 2024Immunovia AB (publ)Sweden0.77%still open
September 3, 2024Dicot Pharma ABSweden2.37%still open
September 2, 2024Dicot Pharma ABSweden2.25%still open
August 30, 2024Dicot Pharma ABSweden2.10%still open
August 27, 2024Immunovia AB (publ)Sweden1.90%still open
August 27, 2024Dicot Pharma ABSweden1.81%still open
August 26, 2024Dicot Pharma ABSweden1.43%still open
August 23, 2024Immunovia AB (publ)Sweden1.58%still open
August 23, 2024Dicot Pharma ABSweden1.04%still open
August 22, 2024Immunovia AB (publ)Sweden1.77%still open
August 22, 2024Dicot Pharma ABSweden0.95%still open
August 22, 2024Logistea ABSweden0.50%still open
August 20, 2024Immunovia AB (publ)Sweden1.37%still open
August 20, 2024Dicot Pharma ABSweden0.70%still open
August 19, 2024Immunovia AB (publ)Sweden1.08%still open
May 16, 2024Oncopeptides ABSweden0.75%still open
May 15, 2024Oncopeptides ABSweden0.67%still open
April 22, 2024Nobia ABSweden1.01%still open
April 19, 2024Nobia ABSweden0.86%still open
April 12, 2024Nobia ABSweden0.64%still open
April 9, 2024Tobii ABSweden0.60%still open
April 3, 2024Tobii ABSweden0.72%still open
March 26, 2024Tobii ABSweden0.61%still open
March 21, 2024Acconeer ABSweden0.60%still open
June 16, 2023Precise Biometrics ABSweden3.34%still open

Download as CSV

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Guevoura Fund, data as at August 10, 2026, https://www.quivad.com/detenteur/guevoura-fund?page=3